G6PD DEFICIENCY and
HEMOLYTIC ANEMIA
G6PD deficiency is a form of inherited disorder (that
occurs mostly in males) in which body lacks an enzyme which normally protects RBCs
from toxic chemicals.
G6Pd deficiency is
commonest enzymopathy of RBCs,
BACK GROUND INFORMATION NECESSARY TO
UNDERSTAND THE DISEASE
Applied
biochemistry ,red cell enzymes
1.Matured
RBCs lack nucleus,mitochondria and ribosomes.
And
no tricarboxylic acid cycle and no synthesis of new proteins
2.To
maintain integrity –rely on glycolysis
3.Natural
decay of enzyme activity ends the life
span of RBC
Energy for RBCs
RBCs require constant
energy to maintain biconcave disk form and
hemoglobin
in reduced state.
without
enrgy RBC lyse,deform
Energy is derived by
metabolizing glucose by 2 pathways
1.Aerobic pathway- pentose
phosphate shunt
2.via anerobic pathway
Embden Myerhof pathway
(Most important is Hexose
monophosphate shunt)
Metabolism of glucose
Via hexose monophosphate shunt
By metabolising glucose,ATP is produced
Glucose is metabolized to pyruvate by number of enzymes.(important
-Pyruvate kinase)
G6PD- (Glucose 6 phosphate dehydrogenase ) is the first
enzyme which takes part in the above shunt.
The above shunt generates
NADPH through the enzyme G6PD
NADPH keeps
glutathione(GSSG) in reduced state(GSH)
This GSH protects RBC
proteins from oxidative damages;reduced
glutathione acts as a scavenger of free
radicles.
In response to oxidant stress
normal RBCs produce NADPH
Pathophysiology of Hemolysis
When there is defientG6PD
enzyme, NADPH production is impaired
So,unable to withstand
oxidative stress,damage occurs to
sulph hydryl group of Hemoglobin
and RBC cell membrane
causing hemolysis
Note:
·
Oxidative damage
occurs due to free radicles created by
conversion of oxy to deoxy HB
and
peroxidases created by phagocyting granulocytes
·
Other cells in
other tissues have alternative pathways to generate NADPH
·
Enzymes of
reticulocytes are very active but as cell ages activity falls.G6PD deficiency
worsens as RBCs age .During periods of oxidative stress, hemolysis begins with
oldest RBCs and progressively involves younger RBCs depending on severity.As
RBCS do not have nuclei, when G6PD degrades,there is no G6PD mRNA to replace it.
BIOCHEMICAL PATHWAY –
THE HEXOSE MONOPHOSPHATE SHUNT
THE HEXOSE MONOPHOSPHATE SHUNT
ANEROBIC PATHWAY |
PENTOSE PHOSPHATE PATHWAY-Aerobic pathway |
Variants of the
enzyme
About 100 variants exist
in G6PD deficiency
Normal type –TypeA
and B
Unstable variant found in
affected male Africans
Unstable Variant A called A--
Reticulocytes in A—have normal activity but
declines with age(hemolysis is self limiting)
Variant TypeB—
seen in Mediterraneans
;activity very low,so hemolysis severe.
WHO working group classification
Class I ; Severely deficient with chronic non spherocytic
hemolytic anemia
ClassII; Severly deficient with acute intermittent
hemolysis(G6PD meditteranean)
CLASSIII: Moderately
deficient with intermittent
hemolysis usually associated with infection or drugs
ClassIV: Normal activity(60% -150%)
ClassV: Increased activity
(>150%)
TRANSMISSION OF
THE DISEASE
Transmission is X linked
through a defective G6PD gene located on X chromosome
Mutation of that gene.
Therefore typically
affects men
Since this is a X linked gene,prevalence
in females –higher but females are usually asymptomatic
Expression of disease
occurs in
Hamizygous
male and
Homozygous
females
(Males possess only one
copy of the gene thus they are either normal or G6PD deficient.
Heterozygous females
withG6PDD have 2RBC populations;one normal,one withenzyme deficiency)
Affected people are intolerant to oxidative
stress ,result is hemolysis
X chromosome and the position of G6PD gene atXq28 locus |
.Epidemiology:
About 400 million people affected world wide
Highest prevelance in :
people of African, meditteranian and Asian heritage
G6PD deficiency confers a relative resistance against
plasmodium falciparum
CLINICAL FEATURES
·
Usually
asymptomatic
·
In all
patients severity varies
·
Varies from intermittent hemolysis to chronic
hemolysis
or sudden life threatening intra
vascular hemolysis with loin pain and hemoglobinurea
TYPES OF PRESENTATION
!. Acute Hemolysis
2. Intermittent hemolysis
#. Chronic mild hemolysis
4. Drug induced hemolysis
5.Favism
6. Neonatal jaundice
7. Congenital non spherocytic hemolytic anemia
1. ACUTE HEMOLYTIC ANEMIA
After remaining asymptomatic
Sudden hemolysis 2-3 days after precipitating factor
Abrupt fall in Hemoglobin to 4 gms /dlrange
In 5-7 days reticulocytes increase and reverse anemia
even without removal of the drug
In Meditteranean type –severe form- hemolysis
continues even after withdrawl of drug.
2. DRUG INDUCED HEMOLYTIC ANEMIA
Occurs with all types
severe in medetteranean and oriental types
In African type –less severe self limiting
Drugs causing
hemolysis
Antimalarials-
primaquin,qunine,chloroquine
Anti bacterials-
Sulpha,nalidixic acid,nitrofurantoin chloromycetin,+pyridium
Anti tuberculous-
Para aminosalicylic acid
Anti lepromatous-
Dapsone
Analgesics-
Aspirin,phenacetin
Vitamin K
Methelene blue--- Antitode for meth hemoglobinemia
Certain Chinese medicines
Food s triggering
Fava beans,fava bean products
Other triggers causing hemolysis
House hold products- Moth balls
Naphthalene containing products
Metabolic precipitant-Diabetic
keto acidosis
Severe Hemolysis and acute
renal failure and death may occur.
3. FAVISM
Severe hemolysis followed by ingesting fava beans
Even inhalation of fava pollens
Occurs in Mediterranean
group
fava beans |
4.INTERMITTENT HEMOLYTIC EPISODES
Provoked by
Pneumonia.
Hepatitis ,Diabetic ketoacidosis
5.CHRONIC MILD
HEMOLYSIS –occurs with some varients
6.NEONATAL
JAUNDICE-
Common in meditteranean and oriental group.
Provoked by Vit K
D.D-Rhesus hemolytic disease of new born
7.Congenital non spherocytic hemolytic anemia
ClassI variant
Defect very severe;normal
stress in circulation cannot be
withstood.
New born period itself-anemia
&jaundice develop.
Severe cases-neutrophilic defect
also associated
NOTE:
In all patients severity varies from clinically
inapparent to dramatic life threatening event.
Physical exam
during hemolysis shows jaundice and spleenomegaly.
Tests for
G6PD deficiency
1 .Many variants exist in G6PD deficiency (about 100)
2. Old cells hemolyse more thanyoung RBC,since they
contain more enzymes
5. G6PD assay Just after hemolysis can be misleading
since new normal cell are released into circulation
6. In young cells G6PdD >6PGD.So,G6Pd/6pgd ratio will
give correct picture in acute hemolysis.
7 .G6PD/6PGD ratio
help to detect heterozygotes
Screening
tests for G6PD deficiency are available
After initial screening ,select patients for further
investigations
Best technique Spectro photometer assay
If equivocal reassay after few weeks if clinical
suspicion exists
More sensitive is Electrophoretic technique.
DIFFERENTIAL DIAGNOSIS for G6PD deficiency
Hemolytic anemia
Sickle cell anemia
Heriditary sphrocytosis
INVESTIGATIONS
CBC
Reticulocyte count
Urine analysis
LDH/Hepatoglobin
Serum haptoglobin level
will reduce in hemolysis ;is an index of hemolysis
Fractionated bilirubin
Blood smear with stains
for Heinz bodies They are denatured hemoglobin.within RBCS
G6PD fluroscent Spot test
This
test looks for fluorecense of NADPH
In
this disease when NADPH is absent ,fluorescence is absent
G6PD spectrophotometry
Genetic test variant
Imaging studies
Abdominal USG shows
splenomegaly and gall stones
TREATMENT
Avoid offending drugs and
any other precipitating agents
Supportive care(oxygen,bed
rest)
In neonatal jaundice
phototherapy or exchange transfusion
Adequate hydration to
avoid renal failure
Transfusion
Folic acid
Vitamin E as antioxidant
(Efficiecy?)
Splenectomy
One Significant
Complication
Myoglobinuria or
hemoglobinuria from hemolysis can cause
Acute Tubular Necrosis
Microscopic exam of urine shows granular casts;
Microscopic exam of urine shows granular casts;
Urine is reddish brown .
Pathogenesis
Heme pigment casts
obstruct the tubles,volume depletion and ischemia
FeNa less than one percent as against typical ATN
This shows that there is tubular obstruction rather than
ischemia.
_________________
0 comments:
Post a Comment